ArticleCellular oncology (Dordrecht, Netherlands)2017

Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma.

Miodrag Dragoj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.